Bohnen Shane 4

Accession 0001062993-25-014699

CIK 0000842023other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 5:28 PM ET

Size

31.2 KB

Accession

0001062993-25-014699

Form 4

Period: 2025-08-15

SVP - General Counsel

Transactions

Award
Restricted Stock Units
2025-08-15+6,996→ 6,996 total
→ Common Stock (6,996 underlying)
Tax Payment
Common Stock
2025-08-15$53.60/sh−527$28,247→ 4,385 total
Exercise/Conversion
Restricted Stock Units
2025-08-15−50→ 49 total
→ Common Stock (50 underlying)
Exercise/Conversion
Restricted Stock Units
2025-08-15−1,668→ 3,338 total
→ Common Stock (1,668 underlying)
Award
Stock Option (Right to Buy)
2025-08-15+17,897→ 17,897 total
Exercise: $53.60Exp: 2035-08-15→ Common Stock (17,897 underlying)
Exercise/Conversion
Common Stock
2025-08-15+1,718→ 4,912 total
Award
Performance Restricted Stock Units
2025-08-15+13,992→ 13,992 total
→ Common Stock (13,992 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (8,848 underlying)
8,848
Stock Option (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (3,460 underlying)
3,460
Restricted Stock Units
→ Common Stock (2,259 underlying)
2,259
Stock Option (Right to Buy)
Exercise: $73.76Exp: 2030-04-03→ Common Stock (3,928 underlying)
3,928
Stock Option (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (16,302 underlying)
16,302
Performance Restricted Stock Units
→ Common Stock (10,012 underlying)
10,012
Stock Option (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (8,944 underlying)
8,944
Stock Option (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (3,508 underlying)
3,508
Performance Restricted Stock Units
→ Common Stock (4,802 underlying)
4,802
Performance Stock Option (Right to Buy)
Exercise: $84.61→ Common Stock (12,924 underlying)
12,924
Stock Option (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (13,488 underlying)
13,488

Footnotes (14)

[F1]Fully exercisable.
[F10]1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
[F11]Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
[F12]Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F13]2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
[F14]Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028.
[F2]Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
[F3]Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
[F4]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F5]2,259 restricted stock units vest on 4/3/2026.
[F6]Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
[F7]49 restricted stock units vest on 8/15/2026.
[F8]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F9]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother